MULTIMODAL NEUROPROTECTIVE THERAPY OF COMORBID PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA
https://doi.org/10.21518/2079-701X-2017-17-146-150
Abstract
The article reviews the etiological factors and pathophysiological mechanisms by which the cerebral vascular insufficiency develops and advances. It presents the main directions in the treatment of such patients including the combined use of polymodal drugs with neuroprotective, metabolic and vascular effects.
About the Authors
M. Yu. Martynov
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD, Prof., Associate of RAS.
Moscow
A. N. Yasamanova
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD, Prof.
Moscow
T. I. Kolesnikova
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
PhD in medicine.
Moscow
I. A. Schukin
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
PhD in medicine.
Moscow
A. P. Glukhareva
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
Moscow
V. I. Chubykin
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
Moscow
A. I. Koltsov
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
Moscow
M. S. Fidler
Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
Moscow
References
1. Бурцев Е.М. Вопросы классификации, клинического течения и патогенетического лечения дисциркуляторной энцефалопатии. Журнал неврологии и психиатрии имени С.С. Корсакова, 1991, 91: 19-22.
2. Боголепов Н.К. Патология мозгового кровообращения. Актовая речь. М., 1965, 25 с.
3. Гусев Е.И. Ишемическая болезнь головного мозга. Актовая речь. М., 1992, 36 с.
4. Гусев Е.И., Мартынов М.Ю., Ясаманова А.Н., Колесникова Т.И., Кабанов А.А., Петухов Е.Б., Березов В.П. Этиологические факторы и факторы риска хронической сосудистой мозговой недостаточности и ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова, 2001, 1: 41-46.
5. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М., 2001, 326 с.
6. Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга. Журнал неврологии и психиатрии имени С.С. Корсакова, 1985, 85: 1281-1291.
7. Ясаманова А.Н. Гемостаз и липиды крови при острой и хронической ишемии головного мозга. Дисс.. докт. мед. наук. М., 2005, 283 с.
8. Яхно Н.Н., Лаврентьева М.А. Клиникогемодинамические особенности атеросклеротической дисциркуляторной энцефалопатии. Журнал неврологии и психиатрии имени С.С. Корсакова, 1994, 94: 3-5
9. Awad I, Spetzier R, Hodak J, Awad C, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, I: correlation with age and cerebrovascular risk factors. Stroke, 1986, 17: 1084-1089.
10. Bonithon-Kopp C, Levenson J, Scarabin P, et al. Longitudinal associations between plasma viscosity and cardiovascular risk factors in a middle-aged French population. Atherosclerosis,1993, 104: 173-182.
11. Brown G, Garcia J, Gdowski J, Levine S, Helpern J. Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Working hypothesis. Arch Neurol, 1993, 50: 384-388.
12. Cocca A. Circadian rhythm and blood pressure control: physiological and pathological factors. Hypertens, 1994, 12(suppl 5): 13-21.
13. Coffey C, Wilkinson W, Parashos I, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology, 1992, 42: 527-536.
14. Сoull B, Beamer N, de Garmo P, et al. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke, 1991, 22: 162-168.
15. Drayer B. Imaging of the aging brain: 1. Normal findings. Radiology. 1988, 166: 785-796.
16. Ernst E, Matrai A. Abstention from chronic cigarette smoking normalizes blood rheology. Atherosclerosis, 1987, 64: 75-77.
17. Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Trans, 1998, 53(suppl): 31-39.
18. Folsom A, Wu K, Shahar E, Davis C. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb, 1993, 12: 1829-1836.
19. Frishman W, Ooi W, Derman M, et al. Serum lipids and lipoproteins in advanced age. Intraindividual changes. Ann Epidemiol, 1992, 2: 43-50.
20. Goldstein L, Bartrokis G, Hance D, Shapiro D. Relationship between blood pressure and subcortical lesions in the healthy elderly people. Stroke, 1998, 29: 765-772.
21. Grotta J, Ackerman R, Correlia J, et. al. Whole blood viscosity parameters and cerebral blood flow. Stroke, 1982, 13: 296-302.
22. Hachinski V, Potter P, Merskey H. Leuko-araiosis. Arch. Neurol, 1987, 44: 21-23.
23. Heistad DD. Endothelial function in the time of the giants: Paul M. Vanhoutte lecture. J Cardiovasc Pharmacol, 2008, 52(5): 383-92.
24. Howard G, O`Leary D, Zaccaro D, et al. Insulin resistance and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) investigators. Circulation, 1996, 27: 37-43.
25. Jernigan T, Press G, Hesselink J. Methods for measuring brain morphologic features on MRI (validation and normal aging). Arch Neurol, 1990, 47: 27-34.
26. Kannel W, Wolf P, D`Agostino R. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA, 1987, 258: 1183-1186.
27. Kawamura J, Meyer J, Terayama Y, Weathers S. Cerebral hypoperfusion correlates with mild and parenchimal loss with severe multiinfarct dementia. J Neurol Sci, 1991, 102: 32-39.
28. Kobari M, Meyer J, Ichijo M. Leukoaraiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol, 1990, 47: 161-165.
29. Manolio T, Kronmal R, Burke G, et al. Magnetic resonance abnormalities and cardio-vascular disease in older adults. The cardiovascular health study. Stroke, 1994, 25: 318-327.
30. Manolio T, Kronmal R, Burke G, O`Leary D, Price T. Short-term predictors of incident stroke in older adults. Stroke, 1996, 27: 1479-1486.
31. Marchal G, Rioux P, Petit-Taboue M, et al. Cerebral oxygen consumption, blood flow and blood volume in healthy human aging. Arch Neurol, 1992, 49: 1013-1020.
32. Potvin A, Syndulko K, Tourtellotte W, Lemmon J, Potvin J. Human neurologic function and the aging process. J Am Geriatr Soc, 1980, 28: 1-9.
33. Powers W. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol, 1991, 29: 231-241.
34. Schmid-Schonbein H. Macrorheology and microrheology of blood in cerebrovascular insufficiency. Eur Neurol, 1983, 22(suppl 1): 2-22.
35. Streifler J, Fox A, Wong C, Hachinski V, Barnett H. Importance of «silent» brain infarctions in TIA patients with high-grade carotid stenosis: results from NASCET. Neurology, 1992, 42(suppl 3): 204.
36. Vasan RS. Biomarkers of cardiovascular disease. Molecular basis and practical considerations. Circulation, 2006, 113: 2335-62.
37. Watanabe N, Imai Y, Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke,1996, 27: 1319-1327.
38. Whisnant J. Modeling of risk factors for ischemic stroke. The Willis lecture. Strok, 1997, 28: 1839-1843.
39. White R, Markus H. Impaired dynamic cerebral autoregulation in carotid artery stenosis. Stroke, 1997, 28: 1340-1344.
40. Yonas H, Smith H, Durham S. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg, 1993, 79: 483-489.
Review
For citations:
Martynov MY, Yasamanova AN, Kolesnikova TI, Schukin IA, Glukhareva AP, Chubykin VI, Koltsov AI, Fidler MS. MULTIMODAL NEUROPROTECTIVE THERAPY OF COMORBID PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA. Meditsinskiy sovet = Medical Council. 2017;(17):146-150. (In Russ.) https://doi.org/10.21518/2079-701X-2017-17-146-150
Views:
548
Email this article 